Morishita JintanMORISHITA JINTAN CO.,LTD.4524東証スタンダード医薬品FY ending Mar 2026, consolidated, J-GAAP

Morishita Jintan FY ending Mar 2025 results

About 62% of Morishita Jintan's sales come from Solution business division, with Consumer business division and Other making up much of the rest.

Out of every ¥100 of sales, about ¥6 is left as operating profit.

Revenue changed +2.9% from the prior year, operating profit +12.3%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +2.9% · profit +12.3%, calculated from disclosed figures.

Operating leverage: 4.24× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2024 → FY ending Mar 2025

Revenue
+2.9%¥12.4B → ¥12.8B
Gross profit
-0.4%¥6B → ¥5.97B
Operating income
+12.3%¥716M → ¥804M
Net income attributable to owners
-21.5%¥697M → ¥547M
Operating cash flow
+241.3%¥196M → ¥669M
Free cash flow
Loss-¥455M → -¥10M

Where the money goes

FY ending Mar 2024 → FY ending Mar 2025

Where ¥100 of sales goes

For every ¥100 Morishita Jintan sells, how much goes where, and how much is kept.

FY ending Mar 2025
Cost of sales
¥53
SG&A
¥41
Operating profit
¥6
Net profit kept
¥4

Annual margin trends

Gross margin46.8%
FY ending Mar 2020: 53.0%53.0%FY ending Mar 2021: 50.8%50.8%FY ending Mar 2022: 51.0%51.0%FY ending Mar 2023: 46.8%46.8%FY ending Mar 2024: 48.3%48.3%FY ending Mar 2025: 46.8%46.8%FY20FY21FY22FY23FY24FY25
Operating margin6.3%
FY ending Mar 2020: 4.6%4.6%FY ending Mar 2021: 2.4%2.4%FY ending Mar 2022: 3.1%3.1%FY ending Mar 2023: 5.0%5.0%FY ending Mar 2024: 5.8%5.8%FY ending Mar 2025: 6.3%6.3%FY20FY21FY22FY23FY24FY25
Net margin4.3%
FY ending Mar 2020: 3.3%3.3%FY ending Mar 2021: 2.2%2.2%FY ending Mar 2022: 3.0%3.0%FY ending Mar 2023: 4.3%4.3%FY ending Mar 2024: 5.6%5.6%FY ending Mar 2025: 4.3%4.3%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2025

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第89期(2025/04/01-2026/03/31)

    ID S100YE3I2026-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第88期(2024/04/01-2025/03/31)

    ID S100W0BR2025-06-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第87期(2023/04/01-2024/03/31)

    ID S100TRZ72024-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第86期(2022/04/01-2023/03/31)

    ID S100R8RC2023-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第85期(令和3年4月1日-令和4年3月31日)

    ID S100OJ6V2022-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第84期(令和2年4月1日-令和3年3月31日)

    ID S100LOVX2021-06-29Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.